Exagen logo_440x386 (1).jpg
Exagen Inc. to Participate in Investor Summit Group’s Q2 Conference
20. April 2022 16:05 ET | Exagen Inc.
SAN DIEGO, April 20, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in Investor Summit Group’s Q2...